Exchange: NASDAQ·Updated 09:44 AM EDT
ELTX logo

ELTX Elicio Therapeutics Inc

$2.54
$0.015
(0.59%)
Today
Mkt Cap$67.02M
Vol1,519.00

About ELTX

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
49

Neutral Sentiment

How do you feel about ELTX?

Advertisement|Remove ads.